Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIMESULIDE vs NIRSEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIMESULIDE vs NIRSEVIMAB: Safety Overview

Metric NIMESULIDE NIRSEVIMAB
Total FAERS Reports 996 247
Deaths Reported 244 5
Death Rate 24.5% 2.0%
Hospitalizations 408 149
Average Patient Age 49.7 yrs 0.3 yrs
% Female Patients 66.5% 42.3%
Manufacturer N/A Sanofi Pasteur Inc.
Route N/A INTRAMUSCULAR